26820-93-9

Upstream product

• 1122-58-3 dmap 
• 55552-69-7 2-ethylmalonyl dichloride 
• 119-53-9 2-hydroxy-2-phenylacetophenone 
• 36239-09-5 ethyl chlorocarbonylacetate 

Downstream Products

• 147594-02-3 (E)-ethyl α-<<3-<(1,1-dimethylethyl)dimethylsiloxy>phenyl>methylene>-4,5-diphenyl-2-oxazoleacetate 
• 147594-03-4 (Z)-ethyl α-<<3-<(1,1-dimethylethyl)dimethylsiloxy>phenyl>methylene>-4,5-diphenyl-2-oxazoleacetate 
• 1313743-13-3 4,5-bis[4-[[(2S)-1-oxo-2-[[(phenylmethoxy)carbonyl]amino]propyl]amino]phenyl]-2-oxazoleacetic acid ethyl ester 
• 1313743-11-1 4,5-bis[4-[[(2S)-1-oxo-2-[[(phenylmethoxy)carbonyl]amino]propyl]amino]phenyl]-2-oxazoleacetic acid 
• 1313750-85-4 C₁₉H₁₉N₃O₃ 
• 1313750-84-3 C₁₉H₁₅N₃O₇ 
• 147594-10-3 1-Methylethyl-4,5-diphenyl-2-oxazoleacetate 
• 152495-13-1 ethyl α-<<3-<2-(1,1-dimethylethoxy)-2-oxoethoxy>phenyl>methyl>-4,5-diphenyl-α-(2-propenyl)-2-oxazoleacetate 
• 147593-93-9 ethyl α-<<3-<<(1,1-dimethylethoxy)carbonyl>methoxy>phenyl>methyl>-4,5-diphenyl-2-oxazoleacetate 

Relevant academic research and scientific papers

HEPATITIS C VIRUS INHIBITORS

The present disclosure is generally directed to antiviral compounds, and more specifically directed to compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such compounds, and methods for inhibiting the function of the NS5A protein

Nonprostanoid prostacyclin mimetics. 4. Derivatives of 2-[3-[2-(4,5- diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid substituted α to the oxazole ring

The 4,5-diphenyloxazole derivatives 2-4 were previously identified as nonprostanoid prostacyclin (PGI2) mimetics. A series of derivatives of 2-4 bearing substitutents at the carbon atom α to the oxazole ring were synthesized and evaluated as in

Oxazole carboxylic acid derivatives

A novel series of oxazole derivatives is disclosed in the Formula I STR1 wherein Y and Z are independently hydrogen or together form a bond; X is CN, CO2 R1 or CO.NR2 R3 ; R and R1 are independently o